JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, B. H.
Right arrow Articles by Kim, M.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, B. H.
Right arrow Articles by Kim, M.-S.

Vol. 293, Issue 2, 634-640, May 2000

Direct Block by Bisindolylmaleimide of Rat Kv1.5 Expressed in Chinese Hamster Ovary Cells1

Bok Hee Choi, Jin-Sung Choi, Seong-Whan Jeong, Sang June Hahn, Shin Hee Yoon, Yang-Hyeok Jo and Myung-Suk Kim

Departments of Physiology (B.H.C., J.-S.C., S.J.H., S.H.Y., Y.-H.J., M.-S.K.) and Biochemistry (S.-W.J.), College of Medicine, The Catholic University of Korea, Seoul, Korea

The interaction of bisindolylmaleimide (BIM), widely used as a specific protein kinase C (PKC) inhibitor, with rat brain Kv1.5 (rKv1.5) channels stably expressed in Chinese hamster ovary cells was investigated using the whole-cell patch-clamp technique. BIM (I) and its inactive analog, BIM (V), inhibited rKv1.5 currents at +50 mV in a reversible concentration-dependent manner with an apparent Kd value of 0.38 and 1.70 µM, respectively. BIM (I) accelerated the decay rate of inactivation of rKv1.5 currents but did not significantly modify the kinetics of current activation. Other specific PKC inhibitors, chelerythrine and PKC 19-36, had no effect on rKv1.5 and did not prevent the inhibitory effect of BIM (I). The inhibition of rKv1.5 by BIM (I) and BIM (V) was highly voltage-dependent between -30 and 0 mV (voltage range of channel opening), suggesting that both drugs interact preferentially with the open state of the channel. The additional inhibition by BIM (I) displayed a voltage dependence (delta  = 0.19) in the full activation voltage range positive to 0 mV, but was not shown in BIM (V) (delta  = 0). The rate constants of association and dissociation for BIM (I) were 9.63 µM-1 s-1 and 5.82 s-1, respectively. BIM (I) increased the time constant of deactivation of tail currents from 26.35 to 45.79 ms, resulting in tail crossover phenomenon. BIM (I) had no effect on the voltage dependence of steady-state inactivation. BIM (I) produced use-dependent inhibition of rKv1.5, which was consistent with the slow recovery from inactivation in the presence of drug. These results suggest that BIM (I) directly inhibits rKv1.5 channels in a phosphorylation-independent, and state-, voltage-, time-, and use-dependent manner.

1 This work was supported by the Catholic Medical Center Research Fund for special projects (1997).

0022-3565/00/2932-0634$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
S. E. Kim, H. S. Ahn, B. H. Choi, H.-J. Jang, M.-J. Kim, D.-J. Rhie, S.-H. Yoon, Y.-H. Jo, M.-S. Kim, K.-W. Sung, et al.
Open Channel Block of A-Type, Kv4.3, and Delayed Rectifier K+ Channels, Kv1.3 and Kv3.1, by Sibutramine
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 753 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
H. S. Ahn, S. E. Kim, B. H. Choi, J.-S. Choi, M.-J. Kim, D.-J. Rhie, S. H. Yoon, Y.-H. Jo, M.-S. Kim, K.-W. Sung, et al.
Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1714 - C1722.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Lagrutta, J. Wang, B. Fermini, and J. J. Salata
Novel, Potent Inhibitors of Human Kv1.5 K+ Channels and Ultrarapidly Activating Delayed Rectifier Potassium Current
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1054 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
B. H. Choi, J.-A. Park, K.-R. Kim, G.-I. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, M.-H. Kim, Y.-H. Seo, and Y.-G. Kwak
Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C425 - C436.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Thomas, B. C. Hammerling, A.-B. Wimmer, K. Wu, E. Ficker, Y. A. Kuryshev, D. Scherer, J. Kiehn, H. A. Katus, W. Schoels, et al.
Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X)
Cardiovasc Res, December 1, 2004; 64(3): 467 - 476.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
B. H. Choi, J.-S. Choi, D.-J. Rhie, S. H. Yoon, D. S. Min, Y.-H. Jo, M.-S. Kim, and S. J. Hahn
Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1461 - C1468.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.